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Department of Biochemistry, University of Leicester, Leicester, United KingdomABSTRACT Calponin is an actin- and calmodulin-binding protein believed to regulate the function of actin. Low-resolution
studies based on proteolysis established that the recombinant calponin fragment 131–228 contained actin and calmodulin
recognition sites but failed to precisely identify the actin-binding determinants. In this study, we used NMR spectroscopy to
investigate the structure of this functionally important region of calponin and map its interaction with actin and calmodulin at
amino-acid resolution. Our data indicates that the free calponin peptide is largely unstructured in solution, although four short
amino-acid stretches corresponding to residues 140–146, 159–165, 189–195, and 199–205 display the propensity to form
a-helices. The presence of four sequential transient helices probably provides the conformational malleability needed for the
promiscuous nature of this region of calponin. We identified all amino acids involved in actin binding and demonstrated for
the first time, to our knowledge, that the N-terminal flanking region of Lys137-Tyr144 is an integral part of the actin-binding
site. We have also delineated the second actin-binding site to amino acids Thr180-Asp190. Ca2þ-calmodulin binding extends
beyond the previously identified minimal sequence of 153–163 and includes most amino acids within the stretch 143–165. In
addition, we found that calmodulin induces chemical shift perturbations of amino acids 188–190 demonstrating for the first
time, to our knowledge, an effect of Ca2þ-calmodulin on this region. The spatial relationship of the actin and calmodulin contacts
as well as the transient a-helical structures within the regulatory region of calponin provides a structural framework for under-
standing the Ca2þ-dependent regulation of the actin-calponin interaction by calmodulin.INTRODUCTIONCalponins are multifunctional proteins thought to play a role
in modulating the function of actin in smooth muscle and
nonmuscle cells (1). In vertebrates, three calponin genes
have been found to code for three isoforms: basic or h1 cal-
ponin, neutral or h2-calponin, and acidic or h3-calponin (2).
The calponins are modular proteins made of two unique
amino-acid motifs found in many proteins (1). An
N-terminal domain (residues 29–130) named the calponin
homology domain (CH domain) is found in many actin-
binding proteins and signaling proteins. A second protein
motif made of a 23–29 amino-acid stretch is present in three
copies in h1-calponin (residues 164–189, 204–229, and
243–268). The calponin repeat displays sequence similarity
with a number of actin-binding proteins including the
smooth muscle protein SM22a, the Drosophila mela-
nogaster muscle protein mp20, the rat neuronal protein
np25, and the UNC-87 protein of the Caenorhabditis ele-
gans body wall muscle.
The biological function of calponin remains poorly
understood. However, biochemical analysis suggests a role
in modulating actin function. h1-calponin binds both skel-
etal and smooth muscle actin with a high affinity (Kd:
0.35 mM and 0.045 mM, respectively). h1-calponin binding
to actin causes inhibition of the actomyosin Mg2þ-ATPase
and reduces the sliding of actin filaments over myosin inSubmitted July 27, 2010, and accepted for publication January 3, 2011.
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0006-3495/11/04/1718/11 $2.00an in vitro motility assay (3). Actin binding and ATPase
inhibition are reversed by Ca2þ-calmodulin and/or phos-
phorylation of calponin. Thus, h1-calponin was suggested
to play a pivotal role in the regulation of actin-myosin inter-
action. Similarly, it has been suggested that h2-calponin is
involved in the mechanical function of the actin cytoskel-
eton as its expression and degradation are regulated by the
mechanical tension exerted on actin (4). The role of
h3-calponin remains obscure. h3-calponin was reported to
bind actin but not calmodulin (5).
Previously we mapped the actin, calmodulin, and tropo-
myosin binding sites of calponin to a stretch of amino acids
between Ala145 and Tyr182 (6). We tentatively localized the
actin-binding site to the 18-amino-acid sequence
Ala145-Ile163 and identified the sequence Asn153-Ile163 as
a calmodulin binding site (7). A second calmodulin-binding
site (residues 2–51) and a second actin-binding site (resi-
dues 172–187) have been reported by others (8,9). Phos-
phorylation of Ser175 and Thr184 in vitro inhibits the
binding of calponin to actin (10).
Overall, these investigations using classical biochemical
approaches have reached a peptide resolution of the calpo-
nin structure-function relationship. The aim of this study
is to define single calponin amino acids involved in actin
and calmodulin recognition using NMR spectroscopy. Apart
from two reports that obtained 1H, 15N, and 13C resonance
assignments of the calponin CH-domain and its structure
(11,12), no NMR investigations of the calponin regulatory
region or its interaction with actin or calmodulin has beendoi: 10.1016/j.bpj.2011.01.040
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investigation of the calponin 131–228 recombinant peptide
previously shown to contain both actin-binding sites and
one calmodulin-binding site, and to retain the actomyosin
Mg2þ-ATPase inhibitory activity. These studies have
enabled us to identify all amino acids involved in actin-
and calmodulin-binding.MATERIALS AND METHODS
Proteins
F-actin was prepared from Rabbit skeletal muscle acetone powder (13). Re-
combinant fragment of mouse h1-calponin encompassing residues 131–228
(CaP131–228) cDNA cloned in the pMW172 vector was provided by
Dr. Mario Gimona (9). Human liver calmodulin cloned in the pET vector
was provided by Prof. Steve Marston (originated from Dr. Zenon Grabar-
eck’s laboratory). CaP131–228 and calmodulin were expressed in Escher-
ichia coli Bl21 DE3 and purified as previously described (13). 15N-and
15N/13C-labeled CaP131–228 and 15N-labeled calmodulin were prepared
using minimal media supplemented with 15NH4Cl- and
13C-enriched
glucose (Cambridge Isotope Laboratories, Andover, MA), respectively,
using an improved protocol (14). Protein concentrations were determined
by absorbance at 280 nm or by the Lowry assay (13).NMR assignment
The spectra of CaP131–228 were assigned using 15N- and 15N/13C-labeled
samples at concentrations of 800 mM in 20 mM sodium phosphate buffer
pH 7.0 with 20 mMNaCl, 2 mMDTT, and 0.02% sodium azide at a temper-
ature of 278 K. For experiments recorded at other temperatures in the
calmodulin and F-actin binding series, assignments of 1H and 15N reso-
nances were transferred by recording a series of 1H-15N heteronuclear
single quantum correlation (HSQC) spectra at temperature steps of 5 K.
The 15N-labeled sample was used to record 15N HSQC, 1H-15N total corre-
lation spectroscopy (TOCSY)-HSQC, and nuclear Overhauser effect
spectroscopy (NOESY)-HSQC three-dimensional experiments. The
15N/13C-labeled sample was used to record HNCA, HNCO, HN(CO)CA,
HNCACB, HN(CO)CACB, HBHA(CBCA)NH, and HBHA(CBCACO)
NH experiments.
The pulse sequences were used as provided by the manufacturer (Bruker
BioSpin, Billerica, MA). NMR spectra were acquired on model Nos. 500
and 600 MHz Avance spectrometers (Bruker BioSpin) equipped with
z-gradient triple resonance probes. Spectra were processed with TopSpin
software (Bruker BioSpin) and analyzed with CCPN (http://www.ccpn.ac.
uk/ccpn/software/ccpnmr-analysis) (15). The sequence-specific assignment
was obtained by a combination of iterative application of an in-house simu-
lated annealing tool interfaced to analysis (16) and manual analysis. The
assignment is available from the BMRB database, accession code
No. 15719.Dynamics and conformation analysis
Heteronuclear 1H-15N nuclear Overhauser effect (NOE) experiments were
performed at 278 and 298 K using the standard pulse sequence provided by
the manufacturer on an Avance 600 MHz spectrometer (Bruker BioSpin).
The saturation experiment was recorded with a 3.5 s saturation period.
Both saturated and nonsaturated experiments were recorded in interleaved
mode to avoid artifacts. Short internuclear distances were extracted from
a three-dimensional 15N NOESY-HSQC experiment recorded with a mixing
time of 100 ms and at a temperature of 278 K on an Avance 800 MHz spec-
trometer (Bruker BioSpin) equipped with a cryoprobe.CaP131–228-calmodulin interaction experiments
A sample of 700 mM 15N-labeled CaP131–228 was titrated at a temperature
of 298 K with unlabeled human liver Calmodulin at concentrations of
0, 350, 700, 1050, 1400, 1600, and 2100 mM in 20 mM Tris buffer pH
7.5, 50 mM sodium chloride, 10 mM calcium chloride, 1 mM DTT, and
0.02% sodium azide. An 1H-15N HSQC spectrum was recorded at each
point on an Avance 500 MHz spectrometer (Bruker BioSpin). For the
reverse interaction experiment, a sample of 470 mM 15N-labeled calmodulin
was titrated with unlabeled CaP131–228 at concentration of 0, 94, 187, 281,
374, 470, 702, and 936 mM at a temperature of 298 K on an Avance
600 MHz spectrometer (Bruker). The assignment for calmodulin was
initially taken from BMRB entry No. 5893 and supported by three-dimen-
sional 15N-resolved NOESY and TOCSY spectra recorded on the
15N-calmodulin sample at 600 MHz before the titration.F-actin binding titration
Experiments were performed in 10 mM HEPES pH 7.1, 50 mM KCl,
2.5 mM MgCl2, 0.5 mM DTT, and 0.5 mM NaN3 at a temperature of
288 K. To a 200 mM solution of 15N-labeled CaP131–228, an F-actin solu-
tion at a concentration of 17 mg/mL (400 mM) was added in steps of 17 mM
up to a concentration of 85 mM. An 1H-15N transverse relaxation optimized
spectroscopy (TROSY) experiment (17) was recorded at each step on an
Avance 800 MHz spectrometer fitted with a cryoprobe (Bruker).Data analysis
Chemical shift perturbations and changes in peak intensity were analyzed
using CCPN as previously described in Ababou et al. (18). Standard devi-
ations were calculated and the resulting 1*s and 2*s levels are used to
judge the significance of the observed changes.RESULTS
To understand the mode of interaction of calponin with actin
and calmodulin, it is necessary to identify all amino acids
involved in the actin-calponin and calmodulin-calponin
interfaces. In this study, we analyzed the interaction of the
recombinant fragment of mouse h1 calponin encompassing
amino acids 131–228 (CaP131–228) with actin and calmod-
ulin using NMR spectroscopy. This peptide was chosen for
two reasons:
1. Earlier studies have shown that this peptide contains the
main actin- and calmodulin-binding sites responsible for
Ca2þ-dependent actomyosin Mg2þ-ATPase inhibition.
2. This peptide is devoid of theC-terminal region of calponin
reported to negatively interfere with actin binding (19).Two-dimensional heteronuclear spectra
of calponin 131–228
NMR spectroscopy requires the assignment of various peaks
in two- and three-dimensional spectra to individual amino
acids along the peptide chain. Fig. 1 A shows a two-dimen-
sional 1H-15N heteronuclear single quantum correlation
spectrum for 15N-labeled CaP131–228 at 278 K. The
1H-15N HSQC spectrum is typical of an unfolded orBiophysical Journal 100(7) 1718–1728
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FIGURE 1 (A) 1H-15N HSQC two-dimensional spectrum of 15N-labeled
CaP131–228. The experiment is recorded at 600 MHz on a sample of
0.7 mM in actin binding buffer at pH 7.0 and a temperature of 278 K
(5C). Each peak in the spectrum represents one amino acid. (B) Strips
from an 1H-15N 3D NOESY-HSQC experiment recorded at a temperature
of 278 K. The backbone amide regions for two groups of sequential residues
are extracted from the three-dimensional spectrum and arranged in sequen-
tial order. Weak sequential amide-amide NOESY crosspeaks can be identi-
fied that are suggestive of some nascent turn or helical conformations.
1720 Pfuhl et al.partially folded protein with the majority of peaks restricted
to a narrow area 7.5–8.5 ppm. Despite the limited dispersion
of the peaks, they are reasonably well resolved and it is
possible to unambiguously assign all backbone amides
(except for the amino-terminal residue 131, and the four
prolines Pro154, Pro191, Pro198, and Pro222). A complete
assignment of all backbone resonances and a significant
amount of side-chain resonances (1H, 13C, and 15N) has
been obtained and deposited in the BMRB database (acces-
sion No. 15719).
Fig. 1 B shows two sections from three-dimensional
1H-15N-resolved NOESY-HSQC spectra at 278 K expanded
to illustrate (i, iþ1) NOESY crosspeaks for the amino-acid
stretches Gly141-Lys143 and Gly160-Asn162. It is possible to
identify numerous sequential HN-HN NOESY crosspeaks,
typical of an a-helix (Fig. 1 B). A comprehensive analysisBiophysical Journal 100(7) 1718–1728of the NOE connectivities suggests the presence of at least
24 amino acids with HN-HN crosspeaks indicative of at
least a transient, local folded conformation akin to the
well-established nascent helix (20). They are grouped in
four short amino-acid stretches: 140–146, 159–165,
189–195, and 199–205.
CaP131–228 was studied by NMR dynamics experiments
at two different temperatures: 298 K (Fig. 2 A) and 278 K
(Fig. 2 B). At room temperature, the heteronuclear NOE
experiment has virtually only negative peaks (Fig. 2 A,
red), indicative of a disordered, very flexible polypeptide
in which the 1H-15N bond vector undergoes large amplitude
reorientation on a picosecond timescale. In contrast, at
a temperature of 278 K, the heteronuclear NOE intensities
for a number of crosspeaks have become positive
(Fig. 2 B, blue), indicative of a more folded rigid conforma-
tion. The heteronuclear NOEs were quantified and are
plotted as a function of residue number in Fig. 2 C (middle
graph) alongside residues that show sequential amide-amide
NOESY crosspeaks obtained from Fig. 1 A (Fig. 2 C, bottom
line). Note that several distinct segments of modest order at
low temperature (NOEs > 0) emerge in agreement with the
transient helices observed in the NOESY spectrum (indi-
cated by the letter H in the bottom line).Calponin 131–228 binding to actin involves two
short sequences spanning amino acids 138–157
and 179–190
To probe actin binding to the regulatory region of calponin,
we monitored changes in the 1H-15N TROSY spectra of
15N-labeled CaP131–228 titrated with F-actin. Fig. 3 A
shows superimposed TROSY spectra of 200 mM 15N-labeled
CaP131–228 with increasing concentrations of F-actin.
Resonances froma largemolecule such as F-actin have a typi-
cally fast rate of T2 relaxation. This lead to very broad reso-
nance lines which disappear in the experimental noise.
Folded proteins bound to F-actin will have resonances too
broad to be detected and therefore all peaks in the spectra
will disappear in comparison to the free form of the protein.
In unstructured proteins, only residues directly involved in
binding will lose peak intensity whereas resonances of resi-
dues not involved in the binding are still visible in the spec-
trum. Because CaP131–228 is largely unstructured in
solution, it is possible to monitor its binding to F-actin by
loss of peak intensity. A number of peaks show considerable
decrease in their intensities including Thr180 (Fig. 3 B) and
Val142 (Fig. 3 C), while the intensities of a number of other
peaks such as Thr210 and Ser215 remained constant (Fig. 3B).
A summary for the intensity change (the ratio of the peak
intensity obtained in the presence of the highest concentra-
tion of F-actin over the peak intensity obtained with
15N-CaP131–228 alone) is shown in Fig. 3 D. A small
peak ratio implies that the intensity of the corresponding
amino acid was substantially decreased due to its binding
A B
C
FIGURE 2 Heteronuclear 1H-15N NOE experiments for CaP131–228 recorded at 600 MHz in actin-binding buffer at two temperatures: (A) 298 K and (B)
278 K. The signs of the peaks are color-coded with blue for positive and red for negative peaks. Although all peaks in the spectrum are negative at 298 K there
is a significant number peaks with positive sign at 278 K. (C) (Top line) Sequence of mouse h1-calponin 131–228 region. (Graph in themiddle) Heteronuclear
NOEs on a scale of 0.6 to 0.3. (Arrows at end of the bars) Values that go beyond that range. (Bottom line) All residues for which sequential amide-amide
crosspeaks were identified in the three-dimensional 1H-15N NOESY-HSQC experiment. These residues have a propensity to form an a-helical structure.
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change in intensity are not involved in binding to F-actin.
A total of 30 peaks were reduced by >70% of the initial
intensity (19 of them were reduced by >80%).
The amino acids most affected by actin-binding span two
regions. The first region is close to the N-terminus of
CaP131–228 and is comprised of 18 residues: Lys137,
Val138, Asn139, Val140, Gly141, Val142, Lys143, Tyr144,
Ala145, Glu146, Lys147, Asn148, Glu149, Phe152, Glu153,
Glu155, Lys156, and Leu157. The second region encompasses
all 12 residues located between Met179 and Asp190. These
results suggest that these two amino-acid stretches are
involved in tight binding to F-actin. Amino acids bracketed
between these two regions display intermediate peak inten-
sity ratios. Although it is unclear whether this sequence is
involved in actin binding, it is expected to respond to binding
in an indirect manner. Signals from residues C-terminal to
Asn197 retained >65% of their initial peak intensity
throughout the titration, demonstrating that the C-terminal
part of CaP131–228 does not interact with F-actin.Calponin-calmodulin interactions
We have previously demonstrated that the recombinant cal-
ponin fragment CaP131–228 binds to Ca2þ-calmodulin
(13). We therefore aimed to identify the amino acids
involved in Ca2þ-calmodulin using both 15N-labeled
CaP131–228 titrated with unlabeled calmodulin (Fig. 4)
and 15N-labeled calmodulin titrated with unlabeled
CaP131–228 (Fig. 5).
Fig. 4 A displays an 1H-15N HSQC spectrum of 700 mM
of 15N-labeled CaP131–228 titrated with up to 1600 mM
of unlabeled Ca2þ-calmodulin. Numerous peaks show
significant chemical shift perturbations. Fig. 4 B shows the
whole titration for the region of the spectra covering amino
acids Gly141 and Gly165. The chemical shift of Gly165
changes noticeably with each addition of Ca2þ-calmodulin
and the direction of the perturbation is indicated by the
arrow. Chemical shift perturbation is also observed for
Gly141. It is important to note that the resonance peak of
Gly165 showed a split into two peaks across the titrationBiophysical Journal 100(7) 1718–1728
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FIGURE 3 Interaction experiments of CaP131–
228 with F-actin at a temperature of 288 K moni-
tored by 1H-15N TROSY spectra. To a sample of
200 mM 15N labeled CaP131–228, F-actin stock
of 17 mg/mL (400 mM) was added in five steps
(0 mM, dark blue; 17 mM, yellow; 34 mM, blue;
51 mM, brown; 68 mM, green; and 85 mM, red)
and a TROSY spectrum was recorded at each
step. (A) Complete spectrum. (B and C) Smaller
sections. (Dashed boxes) Locations of the smaller
sections in the overall spectrum. (Amino acids in
the smaller sections are labeled in black; those
that show significant changes are labeled in red.)
(D) Overall analysis of the CaP131–238-F-actin
NMR binding data. Peak intensities in the first
and the last step of the titration were measured
and the ratio of the intensity of CaP131–228 peaks
in the presence of F-actin divided by the intensity
of CaP131–228 in the absence of F-actin was
calculated for each residue and plotted against
the sequence of CaP131–228. A bar is drawn at
a value of 0.3 on the Y abscissa corresponding to
a loss of intensity of 70%. Values< 0.3 indicate re-
sidues involved in binding whereas values >> 0.3
suggest no interaction with F-actin.
1722 Pfuhl et al.(the peak starts as a single dark blue but is split into two
peaks after each chemical shift, two green peaks, two
orange peaks.), suggesting two distinct environments for
the proton/nitrogen of this amino acid. Chemical shift
perturbations were also observed for several other amino
acids including Thr180 (Fig. 4 C).
Fig. 4 D illustrates a plot of the chemical shift perturba-
tions obtained from the difference between the values ob-
tained before and after addition of Ca2þ-calmodulin to
15N-CaP131–228 as a function of residue number. Residues
affected by calmodulin binding give a large chemical-shift
perturbation value. Out of a total of 87 observable peaks
in this sample (for a protein of 100 amino acids), we found
combined 1H and 15N chemical shift perturbations above
0.3 ppm for 35 amino acids. The chemical shift perturba-
tions were much larger for 14 amino acids (>0.75 ppm),
suggesting a strong and specific interaction of these residues
with calmodulin.
These 14 residues were located in two regions. The first
region comprises 11 residues within the stretch 149–165:
Glu149, Arg150, Arg151, Phe152, Glu153, Glu155, Lys156,
Leu157, Arg158, Ile164, and Gly165. A further three amino
acids (Leu188, Tyr189, and Asp190) were located 20 residuesBiophysical Journal 100(7) 1718–1728ahead on the amino-acid sequence. In contrast, the chemical
shifts of the first N-terminal 10 residues 131–140 and the
C-terminal 38 amino acids were unperturbed by addition
of Ca2þ-calmodulin. It should be noted that the first region
identified here correspond to the previously known calmod-
ulin-binding site (residues 153–163). However (to our
knowledge), this is the first report of an effect of calmodulin
on residues 188–190. Remarkably, both of these regions
overlap with the two identified actin-binding sites.
We have also investigated the interaction of CaP131–228
with calmodulin using 15N isotope-labeled calmodulin.
Resonance assignment of the backbone amide of the
15N- Ca2þ-calmodulin has been previously published (21)
and was obtained from the BMRB (accession code No.
5893). Fig. 5 A shows the superposition of 1H-15N HSQC
spectrum after the titration of 15N-Ca2þ-calmodulin with
increasing concentrations of CaP131–228. A number of
backbone amides of calmodulin showed significant chemi-
cal shift perturbations. Overall, we collected eight spectra
using a range of CaP131–228 concentration from 0 to
936 mM. Fig. 5, B and C, shows the incremental chemical
shift changes obtained during the titration for several amino
acids. A substantial chemical shift perturbation is seen for
A
B
C
D
FIGURE 4 Titration of 15N-labeled CaP131–
228 with unlabeled calmodulin in calmodulin-
binding buffer at a temperature of 298 K at
500 MHz. The concentration of CaP131–228 was
700 mM and calmodulin was added in eight steps
(dark blue, 0 mM; green, 350 mM; yellow,
700 mM; pink, 1050 mM; blue, 1400 mM; black,
1600 mM; and red, 2100 mM) until a ratio of
CaP131–228:Calmodulin of 1:3 was reached. An
HSQC experiment was recorded at each step. A
large number of residues show significant chemical
shift perturbations in fast exchange. (A) Overall
spectrum. (B and C) Smaller sections. (Dashed
boxes) Locations of the smaller sections in the
overall spectrum. (Amino acids in the smaller
sections are labeled in black whereas those that
show significant changes are labeled in red.) (D)
Summary of the titration of 15N-labeled CaP131–
228 with calmodulin. The combined 1H and 15N
chemical shift differences between the first
(0 mM calmodulin) and the last step (1600 mM
calmodulin) of the titration are plotted against the
sequence. Two bars are drawn at 0.3 ppm and
0.7 ppm chemical shift perturbation.
Calponin—Actin and Calmodulin Interfaces 1723calmodulin amino acids Lys115 (Fig. 5 B) and Thr110 (Fig. 5
C), respectively. On the other hand, the side-chain reso-
nances of Phe141 (Fig. 5 B) and Asp22 and Gln135 (Fig. 5
C) showed a more modest change.
Fig. 5 D represents a plot of the chemical shift perturba-
tions obtained from the difference between the values ob-
tained before and after addition of CaP131–228 to
15N-Ca2þ-calmodulin as a function of residue number. A
high chemical-shift perturbation value suggests a change in
the environment of this residue upon CaP131–228 binding.
Out of a total of 140 observable peaks in this sample (for
a protein of 148 amino acids), we found combined 1H and
15N chemical shift perturbations above 0.7 ppm for 43
calmodulin residues. Out of these 43 residues, 27 were
located in the N-terminal domain 1–69, two were located in
the interdomain linker 69–73, and 14 were located in the C-
terminal domain of calmodulin corresponding to amino acids
74–146. Using the large chemical shift change of Lys155 of
calmodulin during the titration with CaP131–228, we deter-
mined a dissociation constant of 200 mMand a stoichiometry
of 1:1 for the calmodulin-CaP131–228 complex (Fig. 6).DISCUSSION
Calponin binds actin and calmodulin and is colocalized with
actin filaments in the cell. Previous approaches to mapping
the interface among calponin, actin, and calmodulin relied
on the use of protein digestion, short synthetic peptides,
and recombinant fragments (6–8,13). Accurate interpreta-
tion of binding data from these experiments is however,
compromised by several limitations:
1. Not all single amino acids involved in binding will be
identified, because proteolytic and chemical digestion
sites are not necessarily located at the start or the end
of a binding site.
2. It is assumed that the short synthetic peptide or recombi-
nant fragments will adopt the same native conformation
as within the whole parent protein.
3. It is not possible to detect long-range conformational
changes.
Modern NMR spectroscopy is able to overcome these
limitations and simultaneously monitor the behavior ofBiophysical Journal 100(7) 1718–1728
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FIGURE 5 Titration of 15N-labeled calmodulin
with unlabeled CaP131–228 monitored by 1H-15N
HSQC experiments. The sample concentration of
calmodulin was 0.47 mM and CaP131–228 was
added in several steps to give concentrations of
0 (blue), 94 (yellow), 187 (black), 281 (magenta),
374 (green), 470 (violet), 702 (brown), and
936 mM (red). Changes in peak positions are shown
in two selected regions of the spectrum and dis-
played in panels B and C whereas panel A corre-
sponds to the whole spectrum. (Amino acids with
large changes are labeled in red.) (D) Plot of chem-
ical shift perturbations in calmodulin upon interac-
tion with CaP131–228 against the sequence of
calmodulin.
1724 Pfuhl et al.all amino acids in a middle-size protein upon binding to its
targets in solution. In this investigation, we aimed to tackle
outstanding questions on the molecular interactions of cal-
ponin with actin and calmodulin. We started with the
central fragment 131–228 of h1 calponin previously shown
to contain the major actin and calmodulin binding sites
(13).Structural features of the calponin regulatory
region CaP131–228
The dispersion of 1H chemical shifts in the 1H -15N HSQC
experiment combined with the heteronuclear NOE data and
the NOESY crosspeaks show that at room temperature
CaP131–228 is essentially completely unfolded. This is in
agreement with a computer-based prediction of the propen-
sity for disorder of the primary sequence of h1-calponin. By
using two disorder-prediction programs we found that the
sequence covering the CH domain (28–131) displays
a low level of disorder (Fig. 7). Indeed, NMR-based struc-
tural investigations revealed a folded structure for the CHBiophysical Journal 100(7) 1718–1728domain (11,12). In contrast, residues 131–228, covering
the peptide investigated in this study, show a propensity
for disorder (Fig. 7, top). This finding is further supported
by previous circular dichroism analysis showing that calpo-
nin is a flexible molecule with a low a-helical content (22).
Furthermore, CaP131–228 displays a low content of bulky
hydrophobic amino acids (23 out of 98 amino acids), a char-
acteristic feature of unstructured protein sequences (23).
This lack of well-defined structure may provide this part
of the molecule with the ability to recognize different target
proteins, another characteristic of intrinsically disordered
protein sequences (24). The central region of calponin
145–181 has been shown to interact with proteins displaying
a wide spectrum of three-dimensional structures including
actin, myosin, tropomyosin, calmodulin, protein kinase C,
microtubules, and desmin (25–29).
At lower temperature, few residues showed positive
NOE values that overall correlate well with sequential
HN-HN NOESY crosspeaks. This suggests the presence
of transient nascent helices implying a propensity to
assume an a-helical fold (Fig. 7, bottom, indicated by the
FIGURE 6 Plot of the chemical shift perturbations of Lys115 in calmod-
ulin upon titration with CaP131–228 fitted to a quadratic equation for a two-
state binding equilibrium. (Solid squares) Experimental data points.
(Continuous line) Fitted curve. The fitting gives a stoichiometry of 1:1
and a dissociation constant of 200 mM.
Calponin—Actin and Calmodulin Interfaces 1725letter H) (20). At room temperature, and in the absence of
other stabilizing factors, this propensity is not strong
enough to generate a stable fold. However, it is possible
that binding of other proteins induces the folding of these
helices. For example, it has been shown that both F-actin
binding to nebulin (30) and calmodulin binding to masto-
paran (31) stabilize a helical conformation. In this regard,
it is noteworthy that one of the nascent helices in
CaP131–228 (residues 139–144) overlaps with the actin-
binding site whereas another nascent helix, residues
159–165, is located within the calmodulin-binding site
(see the discussion below).Dual site binding of CaP131–228 to F-actin
Our previous studies using proteolysis inferred that actin
binds to the central region of calponin A145–Y181 (6).
Subsequent studies using synthetic peptides further nar-
rowed the main actin-binding site to A145–I163 and identi-fied a second actin-binding site at S175–R185 (7,8). In this
study, we used loss of peak intensity to map all amino acids
involved in actin recognition. Our results show that the
CaP131–228-actin interface is extensive and involves 29
amino acids distributed between two distinct binding
segments K137–L157 and M179–D190.
The first contact site K137–L157 involves 18 amino acids
including: Lys137, Val138, Asn139, Val140, Gly141, Val142,
Lys143, Tyr144, Ala145, Glu146, Lys147, Gln148, Glu149,
Phe152, Glu153, Glu155, Lys156, and Leu157 (Fig. 7,
bottom, indicated by the letter A). This finding identifies
the amino acids involved in actin binding within the previ-
ously characterized actin-binding site 1 (A145–I163) and
demonstrates for the first time that the N-terminal flanking
region of K137–Y144 is an integral part of this actin-binding
site. Only the amino acids 150 and 151 within this sequence
showed no loss of peak intensity upon actin binding, which
suggest that these two amino acids are not in contact
with actin. The inability of three synthetic peptides (T133–
Y144, A145–F152, and Q153–I163), covering the sequence
T133–I163, to interact with actin suggest that all 18 amino
acids within the calponin segment 137–157 form a single
actin-binding site (7). This contact site encompasses the
hexapeptide motif VKYAEK at position 142–147 previously
shown to be necessary for inhibition of the actomyosin
ATPase (13). These data are also consistent withmutagenesis
studies of calponin, which showed that mutation of A145,
K156, and deletion of Val142-Lys147 led to a decrease in the
affinity to actin (13,32). The amino-acid composition of
this site shows a preponderance of hydrophobic and charged
residues. The hydrophobic amino acids are clustered in the
proximal half of this sequence and show a propensity to
form an a-helix.
The second actin-binding segment involves all 12 amino
acids between M179 and D190. This is in agreement with
previous mapping of a second actin-binding site to the
region flanking Tyr182 (8). However, we show that four resi-
dues 175, 176, 177, and 178 previously suggested to be part
of this second actin-binding site, are not in contact withFIGURE 7 Summary of the structure-function
relationship of the central region of calponin as ob-
tained from our NMR data and prediction of disor-
dered regions by two prediction programs, RONN
(top) and IVLSP (bottom). Residues that showed
a loss of intensity upon actin binding are labeled
with the letter A, residues that gave chemical shift
perturbations upon Ca2þ-calmodulin binding are
labeled with the letter C, and residues that showed
a propensity to form an a-helical structure in
NOESY experiments (Fig. 2) and NOE experi-
ments (Fig. 3) are labeled with the letter H. P indi-
cates phosphorylation sites Ser175 and Thr184.
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1726 Pfuhl et al.actin. In contrast, our data identify for the first time residues
186, 187, 188, 189, and 190 as an integral part of this actin-
binding site. Two phosphorylation sites are either in the
vicinity (Ser175) or within (Thr184) this site and this could
explain the reported inhibition of calponin binding to actin
by phosphorylation of calponin at these residues (3,33).
This binding site is also within the first of the C-terminal cal-
ponin repeats (calponin sequence 164–189). Calponin
repeats display homology to sequences within other known
actin-binding proteins (SM22a,C. elegansUNC-87 protein).
In contrast, our data show that the second calponin repeat
(Calponin sequence 204–229) does not interact with actin.
The reason for this difference is currently unclear and being
investigated, but the presence of a proline (residuewith a pyr-
rolidine ring that restricts the geometry of the backbone
chain) in the second repeat (Pro222) might be significant.
Our data are also in agreement with previous findings that
the main actin-binding site of h1-calponin is located outside
the CH domain. In a set of elegant studies, Gimona and
Mital (34) have used transient transfection of fibroblasts
with h1 calponin fragments lacking the N-terminal region,
to show that the CH domain was neither sufficient nor
necessary for calponin interaction with actin. In addition,
a three-dimensional reconstruction of the calponin-actin
complex using a fragment lacking the CH domain also
concluded that this domain does not determine the modes
of calponin binding to actin (35).Calmodulin-CaP131–228 binding interface
The regulatory region of calponin contains at least one
calmodulin binding site as shown by proteolytic fragments
and synthetic peptides (6,7). Synthetic peptides were used
to show that calponin peptide Asn153-Ile163 represents the
minimum sequence necessary for calmodulin recognition
(7). Here we used chemical shift perturbations to map
both calponin and calmodulin residues involved in the cal-
ponin-calmodulin interface and provide a structural basis
for the observed competition between actin and calmodulin
for calponin binding. We found a much larger number of
residues involved in calmodulin binding than the 10 amino
acids previously identified (Fig. 7, bottom, indicated by the
letter C). Overall we found significant chemical shift pertur-
bations for 16 amino-acids including Lys143, Ala145, Glu149,
Arg150, Arg151, Phe152, Glu153, Glu155, Lys156, Leu157,
Arg158, Ile164, and Gly165, Leu188, Tyr189, and Asp190 sug-
gesting their presence in the calponin-calmodulin binding
interface. Interestingly, the amino-acid stretch 149–165
show three common features usually found in calmodulin
binding peptides:
1. A large number of hydrophobic residues (four out of 13).
2. A large number of positively charged residues (five out
of 13).
3. An aptitude to form an a-helical structure.Biophysical Journal 100(7) 1718–1728As discussed above, amino acids 159–165 have the
propensity to form an a-helix and calmodulin binding to
this region may help the folding and the stability of this
single helix. Mapping of calmodulin binding to residues en-
compassed within the stretch 143–165 of CaP131–228 is in
agreement with previous findings from proteolytic and
synthetic peptide studies (6,7). Interestingly we observed
dramatic changes in the chemical shift of three residues
Leu188, Tyr189, and Asp190 located 23 residues away from
the main calmodulin-binding site 143–165. To our knowl-
edge, this is the first report showing an effect of calmodulin
binding on this calponin region. Because it has been shown
previously that the proteolytic fragment 183–192 is unable
to bind calmodulin, it is unlikely that the three-residue
segment 188–190 constitute an independent calmodulin-
binding site. More likely, these amino acids could represent
additional structural determinants for calmodulin binding.
Alternatively, the large chemical shift perturbations
observed for these amino acids could result from large struc-
tural rearrangements of CaP131–228 upon calmodulin
binding to its main site contained within the stretch 143–
165. This interpretation is supported by the previously
reported noncompetitive inhibition of calponin phosphory-
lation at Ser175 and Thr184 by Ca2þ-calmodulin (36). Inspec-
tion of the nature of the 16 amino acids listed above suggests
that both hydrophobic and electrostatic interactions
contribute to the calponin-calmodulin interaction.
Among the residues that display loss of peak intensity on
binding actin, the following also show substantial change in
their chemical shift upon binding calmodulin: Lys143,
Ala145, Glu149, Phe152, Glu153, Glu155, Lys156, Leu157,
Leu188, Tyr189, and Asp190. Hence, calmodulin binding
would appear to sequester a number of amino acids from
the actin binding site 1 and potentially causes global
structural rearrangement that leads to a change in the
conformation of actin-binding elements away from the cal-
ponin-calmodulin interface. This provides a rationale for the
reported competition between calmodulin and actin for cal-
ponin binding previously shown in cosedimentation and
cross-linking experiments (13,28) and explains the observed
reversal of calponin inhibition of actomyosin ATPase by
Ca2þ-calmodulin (37).
Calponin binding to calmodulin is dependent on Ca2þ (2).
Ca2þ binding to calmodulin helix-loop-helix motifs induces
structural changes that lead to the exposition of methionine-
rich hydrophobic stretches which serves to bind target
proteins (38). 1H-15N HSQC spectra of 15N-labeled calmod-
ulin titrated with CaP131–228 were used to map the resi-
dues of calmodulin involved in the binding of calponin.
The NMR data shows that a total of 43 calmodulin amino
acids displayed large chemical-shift perturbations upon
CaP131–228 binding. The induced perturbations were
located in both the N-terminal domain (27 residues) and
the C-terminal half (14 residues) as well as the interdomain
linker (two residues). Inspection of the nature of the
Calponin—Actin and Calmodulin Interfaces 1727calmodulin amino acids involved reveals that half of the
chemical shift perturbations involve hydrophobic residues.
The presence of hydrophobic amino acids on both calponin
and calmodulin at the interface between calponin and Ca2þ-
calmodulin suggests that hydrophobic interactions play an
important role in Ca2þ-calmodulin binding to calponin. In
addition, it is remarkable that seven out of the nine calmod-
ulin methionine residues have presented a noticeable change
in their chemical shift upon interaction with CaP131–228.
The involvement of the so-called ‘‘Methionine puddles’’ in
binding various calmodulin binding proteins including
myosin light-chain kinase and caldesmon is well docu-
mented (39,40).
The fact that the amino acids involved in calponin binding
are largely buried in the apo form would explain why
calmodulin is unable to interact with calponin in the absence
of Ca2þ (see Fig. S8 A in the Supporting Material) (2). In the
presence of Ca2þ, the side chains of six methionines
including Met36, Met71, Met72, Met109, Met145, and Met146
point toward the inside of the molecule, which would
suggest that calmodulin may wrap the calponin peptide in
the same way it does for myosin light-chain kinase calmod-
ulin-binding peptide (see Fig. S8 B) (41). Furthermore,
some of the residues that displayed chemical shift changes
are located in the Ca2þ binding loops I (Thr26, Thr28, and
Glu31) and II (Asp56, Asn60, Asp64, and Glu67) and are
involved in chelating Ca2þ. This could account for the
observed increase in the affinity of calmodulin for Ca2þ in
the presence of calponin (28).
Finally, during the NMR titration experiments, we
noticed that after calmodulin binding, some resonance peaks
were split. The appearance of multiple signals for these resi-
dues suggests the existence of different forms of the
CaP131–228-calmodulin complex. As this doubling is
only observed for the core calmodulin-binding motif around
residues 160–170 which also show a propensity to form an
a-helix, we suggest that a proportion of CaP131–228 would
bind calmodulin in an a-helical structure with the rest
binding in a different way.CONCLUSIONS
In this study, we sought to gain structural insights into the
calponin regulatory region harbored in the peptide 131–
228 using NMR spectroscopy. Although this region is intrin-
sically unstructured, it harbors a number of segments that
have the propensity to form helical structures. Many of these
disordered segments overlap with known target-binding
sites and could potentially fold on binding. It has been sug-
gested that the coupling of folding and binding provides
a structural basis for the formation of highly specific
complexes between a short unstructured sequence and its
targets (42).
However, more-detailed mechanistic insight into the inter-
face between calponin and its biological partners requiresa complete determination of the structure of these complexes
by NMR or crystallography. Furthermore, this study is based
on the use of a calponin fragment covering the central regu-
latory region, and it is important to assess the nature and
extent of the contribution of both the N-terminal CH domain
and the autoinhibitory C-terminal region to actin- and
calmodulin-binding. In addition, the potential contribution
of indirect conformational changes should be borne in
mind, noting in particular the calmodulin-induced chemical
shift observed for the three amino acids (187–189) distal
from the main calmodulin-binding site.SUPPORTING MATERIAL
One figure is available at http://www.biophysj.org/biophysj/supplemental/
S0006-3495(11)00123-8.
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